![]() EXCLUSIVE: Silo Wellness Announces New CEO And Issues Shareholder Letter (OTCQX: NUMIF), a company focused on the development and delivery of innovative mental health care through evidence-based psychedelic-assisted therapies, announced that its shareholders approved the issuance of common shares in connection with the proposed acquisition of. New Acquisition: Novamind To Buy Common Shares Of Numinus Pending Canadian Supreme Court Approval The deal would allow for the extension of both companies’ skillsets towards creating pharmaceutical-grade, standardized drug candidates for diagnoses such. (NASDAQ: JAGX) have signed a letter of intent for a collaboration agreement. Two Psychedelics Drug Development Companies Work To Produce Novel Plant-Based Compounds For Mental Health Disordersįilament Health Corp. Together with the University of Florida, the company is currently studying the effects of psilocybin administration on people who suffer from Binge. ![]() (OTCQB: TRYPF) is a clinical-stage biotech company focused on developing psilocybin-based compounds for ill-treated diseases. Clinical Trials Of Psilocybin Treatment For Overeating Disorder Are Ready, Here's What Results Show So Far Popular for his often controversial views on the Joe. Customs and Border Protection's (CPB) recent seizure of a shipment containing marijuana, psilocybin and MDMA from a private vehicle. Joe Rogan, a cannabis and psychedelics advocate was not pleased about the U.S. Customs Should Take Seized Cannabis & Psychedelics And 'Rethink Their Life' (NEO: CYBN), the biopharma company ‘focused on progressing Psychedelics to Therapeutics’ by creating safe and effective therapeutics for patients to address various mental health disorders, has received Institutional Review Board approval to launch the first-in-human Phase 1/. Cybin Moves Forward With Phase 1/2a Clinical Trial For Treatment Of Major Depressive DisorderĬybin Inc. (OTCQB: MSSTF), a drug discovery & development company creating psychedelic medicines to treat neurological and psychiatric disorders, is currently working on four novel families of next-generation psychedelic compounds, as well as an innovative process to chemically. Mindset Approved For Patent Application Involving Psilocin Derivatives For Central Nervous System Disorders The psychedelics map presents a different panorama. That is to say, well over half the country has some form of legal cannabis, whether for medical or recreational purposes. On a national scale, the current cannabis legal map includes more than two-thirds of the total number of states. Cannabis & Psychedelics Conferences: A List Of Events For This Second Half Of The Year While the whole list of substances is still federally illegal, the discussion has done nothing but expand in a number of states in recent years, greatly supported by clinical studies outlining. Psychedelics’ struggle for acquiring legal status is ongoing, but there is promising news. Read More… MDMA Therapeutic Prescriptions Legalized In Colorado, Once Approved On Federal Level (CSE: ENBI) (OTCQB: ENTBF) to accelerate. (NEO:CYBN) (NYSE: CYBN) announced that, through its wholly-owned subsidiary Cybin IRL Limited, It has entered into an agreement to acquire a Phase 1 N,N-dimethyltryptamine (“DMT”) study from Entheon Biomedical Corp. Largest Phase-1 DMT Study In The Netherlands, A Collaboration Between Entheon & CybinĬybin Inc. The most recent message Musk posted was a reply to a statement by Doug Drysdale, CEO of. Elon Musk Says Psychedelics Should Be Seriously Considered For Therapeutic Uses, Leading Chorus Of Celeb SupportĮlon Musk, the Tesla multi-billionaire investor and owner of the largest portion of Twitter (NYSE: TWTR) shares, has been discussing psychedelics on the social platform. This decision could put the state ahead of its peers to launch the delivery of MDMA-assisted psychotherapy after its expected approval next year. In Colorado, Governor Jared Polis signed a bill that allows for the legal possession and use of MDMA with a medical prescription, provided the drug becomes FDA-approved. The takeover gives Numinus a strong entry into the U.S., with 13 operating wellness clinics across North America, four clinical research sites and a dedicated psychedelics research laboratory.Įlon Musk, Tesla (NASDAQ: TSLA) CEO and one of the most influential thought leaders of the day, shared more proof of his support for psychedelic medicine, tweeting that “psychedelics and MDMA can make a real difference to mental health, especially for extreme depression and PTSD. ![]() Numinus (OTC: NUMIF) concluded its acquisition of Novamind (OTC: NVMDF) in one of the most significant cases of consolidation for the psychedelics industry this year. Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelics Insider.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |